The utility of ADC parameters in the diagnosis of clinically significant prostate cancer by 3.0-Tesla diffusion-weighted magnetic resonance imaging

dc.contributor.authorKus, Aylin Altan
dc.date.accessioned2023-02-21T12:32:31Z
dc.date.available2023-02-21T12:32:31Z
dc.date.issued2021-01-01
dc.description.abstractPurpose: This study has focused on investigating the relationship between the exponential apparent diffusion coefficient (exp-ADC), selective apparent diffusion coefficient (sel-ADC) values, the ADC ratio (ADCr), and prostate cancer aggressiveness with transrectal ultrasound-guided prostate biopsy in patients with prostate cancer. Material and methods: All patients underwent a multiparametric magnetic resonance imaging (mpMRI) including tri-planar T2-weighted (T2W), dynamic contrast-enhanced (DCE), diffusion-weighted sequences using a 3.0-Tesla MR scanner (Skyra, Siemens Medical Systems, Germany) with a dedicated 18-channel body coil and a spine coil underneath the pelvis, with the patient in the supine position. Exp-ADC, sel-ADC, and ADCr of defined lesions were evaluated using region-of-interest-based measurements. Exp-ADC, sel-ADC, and ADCr were correlated with the Gleason score obtained through transrectal ultrasound-guided biopsy. Results: Patients were divided into 2 groups. Group I is Gleason score >= 3 + 4, group II is Gleason score = 6. Sel-ADC and exp-ADC were statistically significant between 2 groups (0.014 and 0.012, respectively). However, the ADCr difference between nonclinical significant prostate cancer from clinically significant prostate cancer was not significant (p = 0.09). Conclusions: This study is the first to evaluate exp-ADC and sel-ADC values of prostate carcinoma with ADCr. One limitation of this study might be the limited number of patients. Exp-ADC and sel-ADC values in prostate MRI imaging improved the specificity, accuracy, and area under the curve (AUC) for detecting clinically relevant prostate carcinoma. Adding exp-ADC and sel-ADC values to ADCr can be used to increase the diagnostic accuracy of DWI.
dc.description.issueMAY 5
dc.description.pagesE262-E268
dc.description.volume86
dc.identifier.doi10.5114/pjr.2021.106071
dc.identifier.urihttps://hdl.handle.net/11443/1124
dc.identifier.urihttp://dx.doi.org/10.5114/pjr.2021.106071
dc.identifier.wosWOS:000656623900001
dc.publisherINT SCIENTIFIC INFORMATION INC
dc.relation.ispartofPOLISH JOURNAL OF RADIOLOGY
dc.subjectprostate cancer
dc.subjectGleason score
dc.subjectdiffusion-weighted imaging
dc.subjectmultiparametric prostate MR
dc.subjectapparent diffusion coefficient
dc.titleThe utility of ADC parameters in the diagnosis of clinically significant prostate cancer by 3.0-Tesla diffusion-weighted magnetic resonance imaging
dc.typeArticle

Files

Collections